Next, we collected tumor specimens from prechemotherapy and postchemotherapy osteosarcoma patients admitted to our hospital and found via immunohistochemistry that OTULIN expression was higher in postchemotherapy patients (n = 6) than in prechemotherapy patients (n = 6) with OS (Fig. 1c, d). The gene discussed is OTULIN; the disease is osteosarcoma.